Is Perjeta a chemotherapy?

Perjeta™ is an anti-cancer (“antineoplastic” or “cytotoxic”) chemotherapy drug.

What does Herceptin and Perjeta do?

By blocking the signals, Perjeta can slow or stop the growth of the breast cancer. Perjeta and Herceptin are examples of immune targeted therapy. In addition to blocking HER2 receptors, Perjeta can also help fight breast cancer by alerting the immune system to destroy cancer cells onto which it is attached.

Is Herceptin chemotherapy?

Herceptin is an intravenous drug that is part of a chemotherapy regimen that is used to prevent recurrence of breast cancer, and for the treatment breast cancer that has spread beyond the breast (metastasized). It belongs to a class of drugs called monoclonal antibodies.

How is Perjeta used in the treatment of cancer?

Perjeta (pertuzumab) is a cancer medication that interferes with the growth and spread of cancer cells in the body.

How much does it cost to take Perjeta a day?

Perjeta (pertuzumab) intravenous solution (420 mg per 14 milliliters) costs about $5,534 if you are paying cash with a discount, or over $99,000 per year. Your insurance will be billed for this medication if you have coverage. You may have additional costs associated with administration of this medication.

When to use Perjeta in combination with Taxotere?

Perjeta was called Omnitarg in earlier studies. to be used in combination with Herceptin and Taxotere before surgery to treat HER2-positive, early-stage (the cancer must be larger than 2 cm or cancer must be in the lymph nodes), inflammatory, or locally advanced-stage breast cancer with a high risk of metastasizing or becoming fatal

How often should Perjeta be given in adjuvant setting?

Patients who begin treatment in the adjuvant setting should receive a total of 1 year (up to 18 cycles) of PERJETA and Herceptin-based therapy, every 3 weeks, starting on Day 1 of the first taxane-containing cycle.